Orphan Drugs Consulting, Mexico
Scientific Affairs Lead
Medical Doctor by the National University of Mexico, with a diploma in Clinical Pharmacology and 28 yrs of experience in Scientific Affairs at pharma industry in Latin America. Dr. Rodriguez holds a certification in Pharmaceutical Medicine by the Royal College of Physicians in UK. Felipe started to contribute with the Biosimilars intake since 2014 by launching the first Infliximab Biosimilar in LatAm. He worked for the past 5 years in the design and implementation of Medical strategy for Pfizer´s Biosimilars portfolio by establish a collaborative partnerships plan with key stakeholders to support the ongoing Biosimilars strategies and development programs.